Back to Dashboard
UTH · Unknown

United Therapeutics Corp Del

USA Unknown Filing: 2026-03-31
33/100
Smart-money confidence1 of 3 sources positive
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
44
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Exchange
YHD
Who's behind the signal
Every informed buyer we can see on UTH, across all three feeds.
Hedge funds · 8
Bridgewater Associates (Dalio) Increased +72%
Baillie Gifford & Co Increased +32%
Citadel Advisors Increased +93%
Millennium Management (Englander) Increased +139%
AQR Capital Management Decreased −36%
Point72 (Steve Cohen) Decreased −20%
+2 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. UNITED THERAPEUTICS CORP DEL isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
0
New positions
4
Increasing
3
Decreasing
1
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Bridgewater Associates (Dalio)
Trust weight: 1.3×
Increased +72%
% of portfolio
0.3%
Position change
+72%
0.3% of Bridgewater Associates's portfolio
Baillie Gifford & Co
Trust weight: 1.4×
Increased +32%
% of portfolio
0.3%
Position change
+32%
0.3% of Baillie Gifford & Co's portfolio
Citadel Advisors
Trust weight: 1.0×
Increased +93%
% of portfolio
0.1%
Position change
+93%
0.1% of Citadel Advisors's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Increased +139%
% of portfolio
0.1%
Position change
+139%
0.1% of Millennium Management's portfolio
AQR Capital Management
Trust weight: 1.0×
Decreased −36%
% of portfolio
0.2%
Position change
−36%
0.2% of AQR Capital Management's portfolio
Point72 (Steve Cohen)
Trust weight: 1.1×
Decreased −20%
% of portfolio
0.2%
Position change
−20%
0.2% of Point72's portfolio
Gotham Asset Mgmt (Greenblatt)
Trust weight: 1.1×
Unchanged
% of portfolio
0.1%
Position change
—
0.1% of Gotham Asset Mgmt's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Decreased −68%
% of portfolio
0.1%
Position change
−68%
0.1% of D.E. Shaw & Co's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to UNITED THERAPEUTICS CORP DEL
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell UNITED THERAPEUTICS CORP DEL or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API